India, Oct. 7 -- Shanchol(R), the oral cholera vaccine originally developed by Shantha Biotechnics, has received prequalification from the World Health Organization (WHO). This milestone enables global procurement agencies such as UNICEF, Gavi, and PAHO to source Shanchol(R) for use in countries where cholera remains a major public health challenge.

"Shanchol(R) was conceived as an affordable, accessible solution for countries facing repeated cholera outbreaks. The WHO prequalification of vaccine carries forward that founding mission,"saidDr K.I. Varaprasad Reddy, Founder of Shantha Biotechnics.

Over the years, close to 40 million doses of Shanchol(R) have been supplied worldwide through UNICEF-led vaccination campaigns. After productio...